We’re heading to New York City for another exciting DCAT Week, the premier global event for companies engaged in the biopharmaceutical manufacturing value chain. Now in its 96th year, DCAT Week is hosted by the Drug, Chemical & Associated Technologies Association (DCAT), and serves to connect industry professionals and provide them with an unparalleled platform to meet, network, ideate, and collaborate for the year ahead.
Like in years past, we’re honored to sponsor 2024’s DCAT Women's Networking Breakfast on Wednesday, March 20 from 6:45-9 a.m. EDT, one of the most highly anticipated events of the week. In addition to ample opportunity for networking, 2024’s DCAT Women's Networking Breakfast will also feature a keynote presentation from New York Times bestselling author and first team captain of the American Women’s Everest Expedition, Alison Levine.
If you’d like to schedule a private meeting with Thermo Fisher Scientific to explore how our industry-leading CDMO services and solutions can support your next drug development and manufacturing project, you may do so below.
Thermo Fisher Scientific’s industry-leading subject matter experts Anil Kane, Executive Director, Global Head of Technical and Scientific Affairs, and Christy Eatmon, Global SME, Sterile Drug Products, will both be available at DCAT Week to discuss how our comprehensive CDMO capabilities for small molecules, large molecules, advanced therapies, clinical trial services, and commercial services can help advance your unique drug development and manufacturing journey.
Drug development and manufacturing is an ever-changing industry. Stay connected to new discoveries, innovations, and expert scientific opinions.
Whitepaper
Transforming CDMO Partnerships Through Quality
Get an in-depth look into key indicators of CDMO quality, with tools and best practices to drive continuous improvement, strengthen collaboration, and ultimately cultivate trust.
View InfographicBlog
What is a CDMO? Seven things to look for in a quality CDMO partner
Learn how CDMOs (contract development and manufacturing organizations) work with pharma companies, and the top considerations companies have when choosing a CDMO partner.
Read BlogWhitepaper
Advancing drug development using in silico modeling
This report provides a framework for that understanding by outlining some of the processes that stand to gain the most from computational modeling and identifying the in silico capabilities that can be used to accelerate and de-risk each phase of development.
Read WhitepaperBlog
CROs vs CMOs, and CDMOs: What’s the difference between the three?
CROs, CMOs, and CDMOs all help biotechnology and pharmaceutical companies with drug development and manufacturing, but what’s the difference between the three?
Read BlogWhitepaper
The changing landscape of oncology drug development: Bringing novel lifesaving therapies to patients
Oncology is the fastest-growing, most active sector of drug development. Matching drug products to clinical and commercial needs requires scientific and technological innovation.
View WhitepaperBlog
Exploring CRDMOs: Reshaping research, development, and manufacturing
CRDMOs, or integrated contract research, development, and manufacturing organizations, are a trend to watch. Discover five benefits of partnering with one.
Read BlogeBook
Protecting tomorrow: Supporting sustainability in the pharmaceutical and biotech industries
Learn how Thermo Fisher is meeting its environmental sustainability goals, and how we work in partnership with the pharma and biotech communities on shared environmental sustainability goals.
View eBookBlog
The 5 Drug Development Phases
To be deemed a “success,” a new drug must make it through five specific phases: 1) discovery and development, 2) preclinical research, 3) clinical research, 4) FDA review, and 5) safety monitoring.
Read BlogWebinar
Optimizing the cell therapy patient journey through integrated CRO CDMO partnership
Watch this on-demand webinar for insights on how working with a single integrated CRO/CDMO partner can help ease industry challenges and provide an accelerated path from development to manufacturing, as well as the benefits that come from unified teams and infrastructure.
Infographic
CDMO Checklist to Launch Your Molecule Globally
Preparing to take your drug into the global market? You’ll need to make sure your CDMO has what it takes to successfully navigate the global regulatory space with speed, security, and supply safeguards. Use this quick list as a reference when evaluating your options.
View Infographic